medigraphic.com
ISSN 2500-7106 (Electronic)
ISSN 0123-2576 (Print)
Medicina & Laboratorio

2021, Number 3

<< Back Next >>

Medicina & Laboratorio 2021; 25 (3)

Evaluation of thyroid nodules with Rapid On-Site Evaluation (ROSE)

Tapia-Vela LJ, Restrepo-Giraldo L

Language: Spanish
References: 53
Page: 581-591
PDF size: 138.50 Kb.


ABSTRACT

Fine needle aspiration (FNA) is a widely used technique due to its high safety and ease of use. However, when used in combination with Rapid On-Site Evaluation (ROSE), there is a reduction in the time required for evaluation and diagnosis, as well as an improvement in the sample quality, a reduction in the number of needle passes and the need to repeat the test, which makes the combined use of both techniques very useful and increasingly requested in the diagnostic imaging and pathology services. ROSE also allows a proper classification of the collected material for cultures, flow cytometry studies and molecular tests. Particularly in patients with thyroid nodules, the performance of ROSE during the ultrasound evaluation and biopsy procedure can guarantee that the sample extracted is sufficient and adequate for the diagnosis, and, likewise, an immediate evaluation for the need for complementary studies can be achieved, providing a fast and accurate diagnosis, reducing the costs related to repeating the procedure, and the morbidity associated with complications from multiple biopsies.


REFERENCES

  1. Díaz-Del Arco C, Ortega-Medina L, Fernández-Aceñero MJ. The role of fine-needleaspiration cytology in the diagnosis of soft tissuenodules: Experience in a tertiary center.Rev Esp Patol 2019;52:147-153. https://doi.org/10.1016/j.patol.2018.10.005.

  2. Schmidt RL, Walker BS, Cohen MB. When is rapidon-site evaluation cost-effective for fine-needleaspiration biopsy? PLoS One 2015;10:e0135466.https://doi.org/10.1371/journal.pone.0135466.

  3. Witt BL, Schmidt RL. Rapid onsite evaluationimproves the adequacy of fine-needle aspiration for thyroid lesions: a systematic reviewand meta-analysis. Thyroid 2013;23:428-435.https://doi.org/10.1089/thy.2012.0211.

  4. Ng DL, Vuhahula E, Zhang L, Waterhouse EG,White KL, Mushi BP, et al. Efficacy of an intensive,ultrasound-guided fine-needle aspirationbiopsy training workshop in Tanzania. J GlobOncol 2018;4:1-9. https://doi.org/10.1200/jgo.18.00134.

  5. Fetzer R, Duey M, Pena V, Wanzer D, KirkpatrickJ, Chau D, et al. Role of cytotechnologistsin rapid onsite adequacy assessmentof cytology materials for diagnostic workupand specimen allocation for ancillary testingusing a standardized protocol. J Am Soc Cytopathol2020;9:67-75. https://doi.org/10.1016/j.jasc.2019.08.005.

  6. Zargham R, Johnson H, Anderson S, Ciolino A.Conditions associated with the need for additionalneedle passes in ultrasound-guided thyroidfine-needle aspiration with rapid on-site pathologyevaluation. Diagn Cytopathol 2021;49:105-108. https://doi.org/10.1002/dc.24605.

  7. VanderLaan PA, Chen Y, Alex D, BalassanianR, Cuda J, Hoda RS, et al. Results fromthe 2019 American Society of Cytopathologysurvey on rapid on-site evaluation-part 1: objectivepractice patterns. J Am Soc Cytopathol2019;8:333-341. https://doi.org/10.1016/j.jasc.2019.07.007.

  8. Shield PW, Cosier J, Ellerby G, Gartrell M,Papadimos D. Rapid on-site evaluation of fineneedle aspiration specimens by cytology scientists:a review of 3032 specimens. Cytopathology2014;25:322-329. https://doi.org/10.1111/cyt.12157.

  9. Kothari K, Tummidi S, Agnihotri M, Sathe P,Naik L. This 'Rose' has no thorns-diagnostic utilityof 'rapid on-site evaluation' (ROSE) in fineneedle aspiration cytology. Indian J Surg Oncol2019;10:688-698. https://doi.org/10.1007/s13193-019-00981-y.

  10. Stevenson T, Powari M, Bowles C. Evolutionof a rapid onsite evaluation (ROSE) servicefor endobronchial ultrasound guided (EBUS)fine needle aspiration (FNA) cytology in a UKhospital: A 7 year audit. Diagn Cytopathol2018;46:656-662. https://doi.org/10.1002/dc.23967.

  11. Sauter JL, Chen Y, Alex D, Balassanian R, CudaJ, Flanagan MB, et al. Results from the 2019American Society of Cytopathology survey onrapid onsite evaluation (ROSE)-part 2: subjectiveviews among the cytopathology community.J Am Soc Cytopathol 2020;9:570-578. https://doi.org/10.1016/j.jasc.2020.06.010.

  12. Schmidt RL, Witt BL, Lopez-Calderon LE,Layfield LJ. The influence of rapid onsite evaluationon the adequacy rate of fine-needle aspirationcytology: a systematic review and meta-analysis. Am J Clin Pathol 2013;139:300-308.https://doi.org/10.1309/ajcpegzmjkc42vup.

  13. De Luca C, Sgariglia R, Nacchio M, Pisapia P,Migliatico I, Clery E, et al. Rapid on-site molecularevaluation in thyroid cytopathology: Asame-day cytological and molecular diagnosis.Diagn Cytopathol 2020;48:300-307. https://doi.org/10.1002/dc.24378.

  14. Burman KD, Wartofsky L. Clinical practice.Thyroid Nodules. N Engl J Med2015;373:2347-2356. https://doi.org/10.1056/NEJMcp1415786.

  15. Medina-Chamorro FM, Calle JA, Stein JE,Merchancano L, Mendoza-Briñez AM, Pulido-Wilches AA. Experience of the implementationof rapid on-site evaluation in ultrasound-guidedfine-needle aspiration biopsy of thyroid nodules.Curr Probl Diagn Radiol 2018;47:220-224.https://doi.org/10.1067/j.cpradiol.2017.06.009.

  16. Maxwell C, Sipos JA. Clinical diagnostic evaluationof thyroid nodules. Endocrinol MetabClin North Am 2019;48:61-84. https://doi.org/10.1016/j.ecl.2018.11.001.

  17. Grani G, Sponziello M, Pecce V, RamundoV, Durante C. Contemporary thyroid noduleevaluation and management. J Clin EndocrinolMetab 2020;105:2869-2883. https://doi.org/10.1210/clinem/dgaa322.

  18. Schlumberger M, Leboulleux S. Current practicein patients with differentiated thyroid cancer.Nat Rev Endocrinol 2021;17:176-188. https://doi.org/10.1038/s41574-020-00448-z.

  19. Vargas-Uricoechea H, Meza-Cabrera I, Herrera-Chaparro J. Concordance between theTIRADS ultrasound criteria and the BETHESDAcytology criteria on the nontoxic thyroid nodule.Thyroid Res 2017;10:1. https://doi.org/10.1186/s13044-017-0037-2.

  20. Michael CW, Kameyama K, Kitagawa W,Azar N. Rapid on-site evaluation (ROSE) forfine needle aspiration of thyroid: benefits, challengesand innovative solutions. Gland Surg2020;9:1708-1715. https://doi.org/10.21037/gs-2019-catp-23.

  21. Ahmadi S, Oyekunle T, Jiang X, Scheri R, PerkinsJ, Stang M, et al. A direct comparison ofthe ATA and TI-RADS ultrasound scoring systems.Endocr Pract 2019;25:413-422. https://doi.org/10.4158/ep-2018-0369.

  22. Melany M, Chen S. Thyroid cancer: Ultrasoundimaging and fine-needle aspiration biopsy.Endocrinol Metab Clin North Am 2017;46:691-711. https://doi.org/10.1016/j.ecl.2017.04.011.

  23. Tessler FN, Middleton WD, Grant EG, HoangJK, Berland LL, Teefey SA, et al. ACR ThyroidImaging, Reporting and Data System (TI-RADS):white paper of the ACR TI-RADS committee. JAm Coll Radiol 2017;14:587-595. https://doi.org/10.1016/j.jacr.2017.01.046.

  24. Fiore E, Rago T, Provenzale MA, Scutari M,Ugolini C, Basolo F, et al. Lower levels of TSHare associated with a lower risk of papillarythyroid cancer in patients with thyroid nodulardisease: thyroid autonomy may play a protectiverole. Endocr Relat Cancer 2009;16:1251-1260. https://doi.org/10.1677/erc-09-0036.

  25. Meller J, Becker W. The continuing importanceof thyroid scintigraphy in the era ofhigh-resolution ultrasound. Eur J Nucl MedMol Imaging 2002;29:S425-438. https://doi.org/10.1007/s00259-002-0811-8.

  26. Matthew T, Olson MAZ. Thyroid fine-needle aspirationand cytological diagnosis. In: Jameson JL,De Groot L, eds. Endocrinology: Adult and pediatric.7th ed: Elsevier; 2016. p. 1417-1422.

  27. Yang W, Fananapazir G, LaRoy J, Wilson M,Campbell MJ. Can The American Thyroid Association,K-TIRADS and ACR-TIRADS ultrasoundclassification systems be used to predict malignancyin Bethesda category IV nodules? Endocr Pract2020. https://doi.org/10.4158/ep-2020-0024.

  28. Tan GH, Gharib H. Thyroid incidentalomas:management approaches to nonpalpablenodules discovered incidentally on thyroidimaging. Ann Intern Med 1997;126:226-231.https://doi.org/10.7326/0003-4819-126-3-199702010-00009.

  29. Singaporewalla RM, Hwee J, Lang TU,Desai V. Clinico-pathological correlation ofthyroid nodule ultrasound and cytology usingthe TIRADS and Bethesda classifications.World J Surg 2017;41:1807-1811. https://doi.org/10.1007/s00268-017-3919-5.

  30. Guth S, Theune U, Aberle J, Galach A, BambergerCM. Very high prevalence of thyroidnodules detected by high frequency (13 MHz)ultrasound examination. Eur J Clin Invest2009;39:699-706. https://doi.org/10.1111/j.1365-2362.2009.02162.x.

  31. Pastorello RG, Destefani C, Pinto PH, CredidioCH, Reis RX, Rodrigues TA, et al. Theimpact of rapid on-site evaluation on thyroidfine-needle aspiration biopsy: A 2-year cancercenter institutional experience. CancerCytopathol 2018;126:846-852. https://doi.org/10.1002/cncy.22051.

  32. Haugen BR, Alexander EK, Bible KC, DohertyGM, Mandel SJ, Nikiforov YE, et al. 2015American Thyroid Association managementguidelines for adult patients with thyroid nodulesand differentiated thyroid cancer: TheAmerican Thyroid Association Guidelines TaskForce on thyroid nodules and differentiatedthyroid cancer. Thyroid 2016;26:1-133. https://doi.org/10.1089/thy.2015.0020.

  33. Detweiler K, Elfenbein DM, Mayers D. Evaluationof thyroid nodules. Surg Clin North Am2019;99:571-586. https://doi.org/10.1016/j.suc.2019.04.001.

  34. Vitagliano G, Santoro G, Landolfi L, CozzolinoI, Peluso AL, Ieni A, et al. Fine-needle cytologyof intraglandular parotid lymph node: Auseful procedure in the management of salivarygland nodules. Diagn Cytopathol 2019;47:695-700. https://doi.org/10.1002/dc.24177.

  35. Horvath L, Kraft M. Evaluation of ultrasoundand fine-needle aspiration in the assessmentof head and neck lesions. Eur Arch Otorhinolaryngol2019;276:2903-2911. https://doi.org/10.1007/s00405-019-05552-z.

  36. Sakairi Y, Nakajima T, Yoshino I. Role ofendobronchial ultrasound-guided transbronchialneedle aspiration in lung cancer management.Expert Rev Respir Med 2019;13:863-870. https://doi.org/10.1080/17476348.2019.1646642.

  37. Jain D, Allen TC, Aisner DL, Beasley MB, CaglePT, Capelozzi VL, et al. Rapid on-site evaluationof endobronchial ultrasound-guidedtransbronchial needle aspirations for the diagnosisof lung cancer: A perspective from membersof the Pulmonary Pathology Society. ArchPathol Lab Med 2018;142:253-262. https://doi.org/10.5858/arpa.2017-0114-SA.

  38. Ravaioli S, Bravaccini S, Tumedei MM,Pironi F, Candoli P, Puccetti M. Easily detectablecytomorphological features to evaluateduring ROSE for rapid lung cancerdiagnosis: from cytology to histology. Oncotarget2017;8:11199-11205. https://doi.org/10.18632/oncotarget.13204.

  39. Bilaçeroğlu S. Molecular markers in lungcancer: role of EBUS. Curr Opin Pulm Med2017;23:247-253. https://doi.org/10.1097/mcp.0000000000000376.

  40. Itonaga M, Ashida R, Kitano M. Endoscopicultrasound-guided fine-needle aspiration (EUSFNA)with image enhancement. Diagnostics2020;10:888. https://doi.org/10.3390/diagnostics10110888.

  41. Coe A, Conway J, Evans J, Goebel M, MishraG. The yield of EUS-FNA in undiagnosedupper abdominal adenopathy is very high. JClin Ultrasound 2013;41:210-213. https://doi.org/10.1002/jcu.22013.

  42. Walia S, Aron M, Hu E, Chopra S. Utility ofrapid on-site evaluation for needle core biopsiesand fine-needle aspiration cytology donefor diagnosis of mass lesions of the liver. JAm Soc Cytopathol 2019;8:69-77. https://doi.org/10.1016/j.jasc.2018.08.001.

  43. Selhi PK, Tyagi R, Bansal P, Kaur H, SoodN. Hepatic fine-needle aspiration cytology:The role of rapid on-site evaluation in the assessmentof hepatic lesions. Turk J Gastroenterol2018;29:442-447. https://doi.org/10.5152/tjg.2018.17466.

  44. Hikichi T, Irisawa A, Bhutani MS, Takagi T,Shibukawa G, Yamamoto G, et al. Endoscopicultrasound-guided fine-needle aspiration of solidpancreatic masses with rapid on-site cytologicalevaluation by endosonographers withoutattendance of cytopathologists. J Gastroenterol2009;44:322-328. https://doi.org/10.1007/s00535-009-0001-6.

  45. de Moura DTH, McCarty TR, Jirapinyo P, RibeiroIB, Hathorn KE, Madruga-Neto AC, etal. Evaluation of endoscopic ultrasound fineneedleaspiration versus fine-needle biopsyand impact of rapid on-site evaluation for pancreaticmasses. Endosc Int Open 2020;8:e738-747. https://doi.org/10.1055/a-1122-8674.

  46. Shi J, Lew M, Zalupski MM, Roh MH, KwonRS, Pang JC. Implication of suspicious cytologyin endoscopic ultrasound-guided fine-needleaspiration for pancreatic cancer. J GastrointestCanc 2015;46:54-59. https://doi.org/10.1007/s12029-014-9681-0.

  47. Ali S, Hawes RH, Kadkhodayan K, Rafiq E,Navaneethan U, Bang JY, et al. Utility of rapidonsite evaluation of touch imprint cytology fromendoscopic and cholangioscopic forceps biopsysampling (with video). Gastrointest Endosc2019;89:340-344. https://doi.org/10.1016/j.gie.2018.08.050.

  48. Lin DM, Tracht J, Rosenblum F, Kouba E, BahlD, Patel A, et al. Rapid on-site evaluation withtelecytology significantly reduced unsatisfactoryrates of thyroid fine-needle aspiration. AmJ Clin Pathol 2020;153:342-345. https://doi.org/10.1093/ajcp/aqz164.

  49. Lin O, Rudomina D, Feratovic R, SirintrapunSJ. Rapid on-site evaluation using telecytology:A major cancer center experience.Diagn Cytopathol 2019;47:15-19. https://doi.org/10.1002/dc.23925.

  50. Gutmann EJ. Something's lost, but something'sgained: On-site evaluation, telecytology, and thecytopathologist. Cancer Cytopathol 2019;127:222-224. https://doi.org/10.1002/cncy.22111.

  51. Lin O. Telecytology for rapid on-site evaluation:Current status. J Am Soc Cytopathol 2018;7:1-6. https://doi.org/10.1016/j.jasc.2017.10.002.

  52. Ohori NP, Landau MS, Manroa P, SchoedelKE, Seethala RR. Molecular-derivedestimation of risk of malignancy for indeterminatethyroid cytology diagnoses. J AmSoc Cytopathol 2020;9:213-220. https://doi.org/10.1016/j.jasc.2020.03.004.

  53. Sanchez A, Bocklage T. Precision cytopathology:expanding opportunities forbiomarker testing in cytopathology. J AmSoc Cytopathol 2019;8:95-115. https://doi.org/10.1016/j.jasc.2018.12.003.




2020     |     www.medigraphic.com